NewsEvents

Your Yourlocation: Home > Long-acting anti-muscarinic drug: tiotropium bromide(136310-93-5)

Tiotropium bromide(136310-93-5) is a long-acting anti-muscarinic drug or anticholinergic agent that has similar affinity for muscarinic receptor subunits M1 and M2. In the respiratory tract, the drug by inhibiting the smooth muscle M3 receptor to play a pharmacological effect, so that bronchial relaxation. Preclinical in vitro and in vivo studies have shown that this product can prevent methacholine-induced bronchoconstriction in a dose-dependent manner lasting up to 24h.

US FDA approved the Boehringer Ingelheimer's tiotropium bromide(136310-93-5) powder inhaler  for the treatment of chronic bronchitis and emphysema and other chronic obstructive pulmonary disease (COPD) caused by bronchial spasm. This product by puncturing the device containing tiotropium bromide powder capsules, so that the drug powder dispersed in the air for the patient inhalation. This standard capsule contains tiotropium bromide(136310-93-5) 18μg, the recommended dose of 1 day to HandHaler inhalation device inhalation of a capsule content.

One-year placebo-controlled study showed an increase in FEV1 of 0.13 L (13%) and a maximum increase of 0.24 L (24%) within 30 min after administration of the first dose. 1 day after treatment 1 week, compared with the average increase in FEV1 was 0.28 ~ 0.31L (28% to 31%). Two 6-month placebo-controlled studies have also improved lung function.

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved